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pituitary (Hafez et al., 2000), it controls sev-
eral complex physiological processes, includ-
ing growth, metabolism, milk synthesis and 
secretion. It is established that administration 
of bovine somatotropin (bST) enhances milk 
ABSTRACT 
Optimal dose of bovine somatotropin (bST) in a sustained-delivery vehicle required for maximum milk 
yield response was estimated in twenty-four lactating West African Dwarf (WAD) goats in three 14-day 
periods using quadratic equation. The goats were divided equally into four treatment groups, each 
comprising  six does. The first group (control, T0) received no bST while the other groups received bST 
(T1, 20 mg; T2, 40 mg; T3, 60 mg) injected at 2-week intervals commencing from the 7th week postpar-
tum for 6 weeks. Does were milked twice daily (7:30 am and 7:30 pm) and milk yield recorded daily. 
Daily milk yield response (DMY) to bST was significantly (p<0.001) influenced by bST dose, day from 
bST treatment and parity during the 2nd period of bST treatment but only bST dose and parity signifi-
cantly influenced (p<0.001) DMY during the 1st and 3rd periods of bST treatment. The mean relative 
response of DMY of bST-treated goats exceeded the control by 48 – 78 % in the entire periods of bST 
administration. Highest predicted response of 80.5 % in the 3rd period and lowest response of 66.2 % 
in the 1st period of bST treatment (when compared to the control) were observed, thus indicating that 
bST positively affected the shape of the lactation curve for possible higher yield in extended lactation. 
Although, the trend of observed and predicted optimal doses of bST needed for maximum DMY were 
well-fitted by the Quadratic equation during the three periods of bST treatment, it varied inconsistently 
with periods of bST treatment (stages of lactation). Therefore, the uniform optimal dose of 50.71 mg 
per 2 weeks estimated by quadratic equations; Y = 141.318 + 4.097X – 0.041X2, R2 = 99.90), Y = 
100.912 + 2.926X – 0.030X2, R2 = 99.49 and Y = 5935.420 + 172.071X – 1.735X2, R2 = 99.49 and 
needed for maximum DMY of 242.86 ml, relative DMY of 74 % and cumulative milk yield response of 
10214.29 ml respectively over the entire periods could be adopted in West African Dwarf goats in or-
der to reduce the complexity of differential injections administered with respect to stages of lactation. 
 
Key words: WAD goats, milk yield, bovine somatotropin. 
INTRODUCTION 
Somatotropin, also known as growth hor-
mone, is a protein hormone of about 190 
amino acids that is synthesized and secreted 
by cells called somatotrophs in the anterior 
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production in dairy ruminants including 
goats (Baldi et al., 2002; Boutinaud et al., 
2003). Administration of a slow-release for-
mulation of bST to dairy ruminants im-
proves persistency of lactation by slowing 
down the rate of post-peak decline (Gallo et 
al., 1997; Chiofallo et al., 1999), changing 
the shape of lactation curve (Gallo et al., 
1997; James, 2009), indicating opportunity 
for extended lactation (Bauman and 
Vernon, 1993; Etherton and Bauman, 1998) 
and thus indicating increased total milk 
yield (Annen et al., 2004). Studies have indi-
cated that bST was administered to dairy 
ruminants for milk yield boost as a single 
bolus, a constant infusion, or as equal epi-
sodic pulses at 4-hr intervals (Bauman and 
McCutcheon, 1986). Typically, bST has 
been administered by daily injection. How-
ever, several sustained- release formulations 
have been developed in which a small vol-
ume is injected at intervals ranging from 2 
to 4 weeks (Chilliard, 1989; Hartnell et al., 
1991; McGuffey et al., 1991) and from 7 to 
8 weeks (Gallo et al., 1997; Chadio et al., 
2000). Regardless, the types of bST, mode 
and form of administration, different doses 
with different milk yield responses have 
been reported in dairy cows (Etherton and 
Bauman, 1998). Information about the use 
of bST in dairy goats is much scarcer. Treat-
ment of temperate dairy goats with bST re-
sulted in increased milk yield (Baldi et al., 
2002; James, 2009) but the galactopoeitic 
response to the exogenous hormone is 
more variable and less intense than that ob-
served for dairy cows (Garsen et al., 1989). 
These observations are much more intense 
with tropical West African Dwarf (WAD) 
goats which have not been selected for 
dairying. Milk yield responses of 48 – 78 % 
to doses of 20 – 60 mg bST per 2weeks of 
administration to WAD goats have been 
reported by James (2009). However, lacta-
tional response to exogenous bST is a func-
tion of daily dose represented by a hyper-
bolic (Bauman and McCutcheon, 1986) or 
quadratic (James, 2009) dose response curve 
with a pattern of diminishing marginal re-
turns to increasing bST dose (McGuffey et 
al., 1991). The daily dose needed to optimize 
milk yield response has been reported to re-
sult in blood concentrations of bST that are 
within the range typically observed during 
episodic release of endogenous hormone but 
average daily concentrations are several-folds 
higher than before treatment. In view of the 
facts that the use of bST to increase milk 
yield in WAD goats is limited, low selection 
intensity of WAD goats for dairying and no 
recommended dose of bST for WAD goats 
in Nigeria, therefore the study was aimed at 
estimating optimal dose of bST needed to 
elicit maximum milk yield response in West 
African Dwarf goats of Nigeria.  
 
MATERIALS AND METHODS 
Description of the experimental site 
The experiment was conducted at the Goat 
Unit of the Teaching and Research Farm of 
the College of Animal Science and Livestock 
Production, University of Agriculture, Abeo-
kuta. Abeokuta falls within the Rain Forest 
Vegetation zone of South-Western Nigeria at 
latitude 7013' 49.46"N, longitude 3026' 
11.98"E (Google Earth, 2006) and altitude of 
76 meters above sea level. The climate is hu-
mid with a mean annual rainfall of 1037 mm. 
The annual mean temperature and humidity 
are 34.70C and 82% respectively. 
 
Experimental animals and their manage-
ment 
Twenty-four West African Dwarf lactating 
does of first and second parities with ages 
between 1.5 and 3 years and whose weights 
ranged from 11 – 16 kg were selected from 
the existing flock on the farm and used for 
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the experiment. The goats were housed in 
cross-ventilated pens with slated floors and 
water given ad libitum. The goats were under 
intensive management system with zero 
grazing (‘cut and feed’) and 0.3 – 0.5 kg/
head/day concentrate feed supplement, 
consisting of about 17% crude protein, 
11.56% crude fibre, 4.68% ether extract and 
2076.70 kcal/kg metabolisable energy was 
fed to the animals. Panicum maximum grass 
was chopped and 1.0 kg/head/day fed to 
the goats. The proximate composition of 
the grass was of 5.37, 33.35, 66.31, 42.79 
and 19.71% of crude protein, crude fibre, 
neutral detergent fibre and acid detergent 
fibre respectively. 
 
Experimental procedure 
Twenty-four lactating does were divided 
equally into four treatment groups, each 
group comprising of six does with first and 
second parity evenly distributed as well as 
liveweight equalization among treatment 
groups. The first group, which was the con-
trol (T0) received no bovine somatotropin 
injection while the remaining three groups 
received bovine somatotropin injections at 
different doses: 20 mg (T1), 40 mg (T2) and 
60 mg (T3). The bovine somatotropin, Lac-
totropina MR, division Sanidad Animal, Eli 
Lilly CO., Mexico is in a sustained-release 
formulation for 14 days interval. 
 
The injections of bovine somatotropin were 
done at the left and right scapular regions 
(Davis et al., 1999) alternately every 14 days 
commencing from 7th to 11th week of lacta-
tion after a 2-week adjustment period with a 
total of 3 injections per doe in 3 periods of 
bST treatment: 1st period (7 – 8 weeks), 2nd 
period (9 – 10 weeks) and 3rd period (11 – 12 
weeks). The doses of bST were selected 
based on the preliminary results obtained by 
Rekwot (personal communication) on the 
study on milk yield and composition of Red 
Sokoto goats treated with bovine somatotro-
pin at the National Animal Production Re-
search Institute (NAPRI), Nigeria. The study 
on the effect of recombinant bovine somato-
tropin (rbST) administration on milk pro-
duction, composition and some haemato-
biochemical parameters of lactating goats in 
Egypt, by Sallam et al. (2005) also provided 
the basis for the selection of the doses. 
 
Data collection 
The West African Dwarf does were milked 
twice daily at 7:30 a.m. and 7:30 p.m. The 
a.m. and p.m. yields were added to determine 
the daily milk yield (DMY). The does were 
milked for 42 days commencing from the 7th 
to the 12th week of lactation. The milk yield 
was measured by a measuring cylinder and 
recorded.  
 
Statistical analysis 
Data generated on DMY of does for each 
period of bST treatment were subjected to 
analysis of variance (ANOVA) in 4 × 14 × 2 
factorial design with 6 replicates using the 
Systat Analytical Computer Package, version 
5.02 (SYSTAT, 1992). The statistical model 
used was: 
 
 
Yijkl = µ + Ai + Bj + Ck + A*Bij + A*Cik + εijkl…………………equation 1 
 
where  Yijkl = Trait of interest  
 Ai  = Fixed effect of ith bST dose (i = 0, 20, 40 & 60 mg) 
 Bj = Fixed effect of jth day from bST treatment (j = day 1 – day 14) 
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 Ck = Fixed effect of kth parity (k = 1st & 2nd) 
 A*Bij  = The interaction between ith bST dose and jth day from bST  
   treatment 
 A*Cik = The interaction between ith bST dose and kth parity of does 
εijkl = Random error associated with each record. 
 
Data generated on cumulative milk yield of does over entire period of bST treatment were 
subjected to analysis of variance (ANOVA) in 4 × 2 factorial design with 6 replicates using 
the Systat Analytical Computer Package, version 5.02 (SYSTAT, 1992). The statistical 
model used was: 
 
Yijk = µ + Ai + Bj + A*Bij + εijk.………………………………..equation 2 
 
where  Yijk = Trait of interest  
 Ai  = Fixed effect of ith bST dose (i = 0, 20, 40 & 60 mg) 
 Bj = Fixed effect of kth parity (k = 1st & 2nd) 
 A*Bij  = The interaction between ith bST dose and jth parity of does 
εijk = Random error associated with each record. 
Estimation of optimal dose of bST for 
maximum milk yield response 
The relative response of DMY of does was 
computed by converting the least squares 
means generated from the ANOVA into 
percentages with 100 % as the minimum 
benchmark. The estimation of optimal dose 
of bST for maximum DMY response, rela-
tive DMY response and cumulative milk 
yield response in WAD does were carried 
out by graphical representations of dose-
response curves. Regressing DMY response 
over bST doses during each period of bST 
treatment and entire period of bST treat-
ment using quadratic equation carried this 
out. The regressions were carried out using 
non-linear regression package (SYSTAT, 
1992) for the generation of lactation curve 
parameters needed for the estimation.    
 
RESULTS AND DISCUSSION 
The summary of least squares analysis of 
variance on the effects of bST dose, day 
from treatment and parity on DMY re-
sponse of WAD does during each period of 
bST treatment is presented in Table 1. Aver-
age DMY response of WAD does was sig-
nificantly (p<0.001) influenced by bST dose, 
day from bST treatment and parity during 
the 2nd period of bST treatment but only 
bST dose and parity significantly influenced 
(p<0.001) DMY response during the 1st and 
3rd periods of bST treatment. In the 1st pe-
riod, average DMY of WAD does increased 
with increasing bST doses with mean values 
of 149.84, 221.17, 236.16 and 254.89 ml for 
T0, T1, T2 and T3 respectively. The relative 
response of DMY of WAD does in T1, T2 
and T3 exceeded T0 by 47.60, 57.61 and 
70.10 % respectively. 
 
The average DMY of WAD does increased 
significantly (p<0.001) with increasing parity. 
In the 2nd period, average DMY of WAD 
does increased with increasing bST doses 
with mean values of 140.41, 218.01, 239.61 
and 232.57 ml for T0, T1, T2 and T3 respec-
tively. 
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Relative response of daily milk yield of 
WAD does in T1, T2 and T3 exceeded T0 by 
55.27, 70.65 and 65.65 % respectively. 
 
The average DMY of WAD does increased 
significantly (p<0.001) with increasing par-
ity. There was significant (p<0.05) interac-
tion between bST dose and parity. Second 
parity does consistently had higher DMY 
even with the same bST dose. In the 3rd pe-
riod, average daily milk yield of WAD does 
increased with increasing bST doses with 
mean values of 129.88, 192.52, 230.02 and 
30.62 ml for T0, T1, T2 and T3 respectively. 
Relative response of DMY of WAD does in 
T1, T2 and T3 exceeded T0 by 48.23, 77.10 
and 78.33 % respectively. There was signifi-
cant (p<0.01) interaction between bST dose 
and parity. Second parity does consistently 
had higher daily milk yield even with the 
same dose. This observation shows the 
strong galactopoietic capacity of bST in en-
hancing milk yield and it corroborates the 
pattern of milk yield of crossbred Alpine 
goats administered bST at three periods last-
ing 28 days each as reported by Chadio et al. 
(2000), even though a higher response of 
DMY to bST treatment was observed in this 
study. Baldi et al. (2002) and Boutinaud et al. 
(2003) using a higher dose in Alpine goats, 
also observed a lower response in DMY, al-
though in these studies treatment with bST 
commenced at the 26th and the 32nd weeks of 
lactation respectively. The disparity to a 
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Table 1: Summary of least squares analysis of variance showing the effects of  
   bovine somatotropin (bST) dose, day from treatment and parity on daily 
   milk yield response of West African Dwarf goats during periods of bST 
   treatment 
  
  
  
Source of variation 
  
  
  
DF 
Mean-Square 
Daily milk yield 
Period in lactation 
1st period 
(7 – 8th week) 
2nd period 
(9 – 10th 
week) 
3rd period 
(11 – 12th week) 
bST dose (D) 
  
Day from bST treatment (T) 
  
Parity (P) 
  
D × T 
  
D × P 
  
Error 
3 
  
13 
  
1 
  
39 
  
3 
  
276 
177029.51*** 
  
2012.52 
  
248221.894*** 
  
401.77 
  
4831.66 
  
3046.01 
175602.12*** 
  
4051.36** 
  
287849.38*** 
  
417.30 
  
5928.47* 
  
1731.90 
190685.31*** 
  
3549.19 
  
197904.38*** 
  
709.61 
  
13978.94*** 
  
2182.61 
*p<0.05, **p<0.01 and ***p<0.001 
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Table 2: Summary of least squares analysis of variance showing the effects of bovine 
 somatotropin (bST) dose and parity on cumulative milk yield response of     
 West African Dwarf goats during lactation 
  
Source of variation 
  
DF 
  
Mean square 
  
Cumulative milk yield 
  
bST dose (D) 
  
Parity (P) 
  
D × P 
  
Error 
  
  
3 
  
1 
  
3 
  
16 
  
22.45E+06** 
  
30.65E+06** 
  
77.39E+04 
  
35.02E+05 
  **p<0.01 
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in WAD does appears to be 50.71 mg 
(Figures 4).  Generally, the optimal dose 
that elicited maximum milk yield in WAD 
does varied inconsistently with period of 
bST treatment (stages of lactation). This is 
because state and activity of mammary tis-
sue differ with stage of lactation. Mammary 
cell proliferation occurs rapidly in early lac-
tation but reduces with late lactation 
(Dijkstra et al., 1997). Therefore, in order to 
reduce the complexity of differential injec-
tions administered with respect to stages of 
lactation, the uniform optimal dose of 50.71 
mg estimated for the entire stages of lacta-
tion could be adopted. The dose stated is 
close to 50.50 mg per 2 weeks observed by 
Rekwot (personal communication) in his 
preliminary findings on Red Sokoto goats in 
National Animal Production Research Insti-
tute of Nigeria. He reported the superiority 
of 50.50 mg bST as against 35.70 mg bST in 
eliciting higher milk yield response in Red 
Sokoto goats, even though, the lower dose 
produced milk yield at par with the higher 
dose towards the end of treatment period. 
Etherton and Bauman (1998) reported that 
the daily dose needed to optimize milk yield 
response results in blood concentrations of 
bST that are within the range typically ob-
served during episodic release of endoge-
nous hormone. Highest predicted response 
of 80.5% in the 3rd period and lowest re-
sponse of 66.2% in the 1st period of bST 
treatment (when compared to the control) 
observed (Figures 1 – 3), indicated that bST 
positively affected the shape of the lactation 
curve. Gallo et al. (1997) considered that this 
response was a medium term effect of bST, 
which improve lactation persistency and in-
crease cumulative milk yield. It can be hy-
pothesized that bST could increase total milk 
yield of WAD does in an extended lactation 
since similar observation has been made on 
Saanen does in 180 days in milk (Baldi et al. 
2002) and Red Sokoto does in 98 days in 
milk (Rekwot, personal communication). 
Therefore, possible commercial use would 
be over the last two thirds or three fourths 
of the lactation cycle (Bauman and Vernon, 
1993. 
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greater extent could be attributed mainly to 
the differences in the breeds of animal used 
and to a lesser extent to doses of bST ad-
ministered, stages of lactation when bST 
was administered, protocols for bST ad-
ministration and formulations of bST used. 
The authors used temperate breeds of goats 
that have long been selected for dairying 
but in this study, we used a tropical breed; 
West African Dwarf goats which has not 
under gone the same extensive selection for 
dairy purpose. Thus, it is expected that 
WAD goats should exhibit greater response 
in DMY to bST treatment. More so, ad-
ministration of bST to lactating goats has 
also increased milk production by 50 – 60 
% (James et al., 1996). The observation that 
the 2nd parity does had higher daily milk 
yield (DMY) than the 1st parity does could 
be attributed to larger udder size with larger 
population of milk secreting cells (alveoli) 
available for higher milk synthesis and se-
cretion. Since udder size is positively corre-
lated with milk yield (James, 2000). Bemji et 
al. (2007) made similar observations in 
WAD and Red Sokoto goats in Nigeria. 
 
The summary of least squares analysis of 
variance on the effects of bST dose and 
parity on cumulative milk yield response of 
WAD does during entire period of bST 
treatment is presented in Table 2. Cumula-
tive milk yield response of WAD does dur-
ing the entire period of bST treatment was 
significantly (p<0.01) influenced by bST 
dose and parity. Cumulative milk yield of 
WAD does increased correspondingly with 
increasing bST doses with mean values of 
5881.75, 8843.83, 9881.17 and 10067.17 ml 
for T0, T1, T2 and T3 respectively. Relative 
cumulative milk yield response to bST treat-
ment of WAD does in T1, T2 and T3 ex-
ceeded T0 by 50.36, 68.00 and 71.16 % re-
spectively. Cumulative milk yield increased 
with increasing parity but there was no sig-
nificant (p>0.05) interaction between bST 
dose and parity. Similar explanations given 
for the observations made on DMY re-
sponse to bST treatment, may also hold for 
the observation made on cumulative milk 
yield response to bST-treated WAD does. 
 
The trends of the observed and predicted 
optimal bST dose for maximum milk yield in 
WAD does during each period of bST treat-
ment were well-fitted in quadratic equations, 
meaning that the response of DMY to bST 
treatment follows quadratic pattern and this 
was shown by their high R2 values (Figures 1 
– 4). This observation agrees with the report 
of McGuffey et al. (1991) who stated that 
lactational response to bST is a function of 
the daily dose represented by a hyperbolic 
dose-response curve with a pattern of dimin-
ishing returns to increasing bST dose. In the 
1st period of bST treatment (7 – 8 week), the 
optimal dose that elicited maximum milk 
yield of 253.71 ml and relative milk yield re-
sponse of 166.20% in WAD does was 54.81 
g (Figures 1). In the 2nd period of bST treat-
ment (9 – 10 week), the optimal dose that 
elicited maximum milk yield of 245.71 ml 
and relative milk yield response of 174.00% 
in WAD does was 45.19 mg (Figures 2). In 
the 3rd period of bST treatment (11 – 12 
week), the optimal dose that elicited maxi-
mum milk yield of 234.86 ml and relative 
milk yield response of 180.50% in WAD 
does was 52.59 mg (Figures 3). The trends of 
the observed and predicted optimal bST 
dose for average, relative and maximum milk 
yield of WAD during entire periods of bST 
treatment were well-fitted in quadratic equa-
tions. The optimal dose that elicited maxi-
mum average milk yield of 242.86 ml, rela-
tive milk yield response of 174.00% and cu-
mulative milk yield response of 10214.29 ml  
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Figure 1a: Observed and predicted optimal dose of bST for      
  maximum daily milk yield response in goats 
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Figure 1: Observed and predicted optimal dose of bST for maximum milk yield 
      response during 1st period (7th – 8th week of lactation) of bST treatment 
      in West African Dwarf goats 
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Figure 2b:Observed and predicted optimal dose of bST for  
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   goats 
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Figure 2: Observed and predicted optimal dose of bST for maximum milk yield 
      response during 2nd period (9th – 10th week of lactation) of bST  
       treatment in West African Dwarf goats. 
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Figure 3:Observed and predicted optimal dose of bST for maximum milk yield     
     response during 3rd period (11th – 12th week of lactation) of bST treatment 
     in West African Dwarf goats 
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Figure 4b:Observed and predicted optimal dose of bST for  
   maximum relative milk yield response in goats 
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Figure 4c: Observed and predicted optimal dose of bST for 
        maximum cumulative milk yield response in goats 
Figure 4c: Observed and predicted optimal dose of bST for maximum milk yield  
      response during entire period (7th – 12th week of lactation) of bST treatment  
       in West Afri can Dwarf goats 
CONCLUSION 
The administration of bovine somatotropin 
(bST) (LactotropinaMR) in a slow-release 
formulation to lactating West African 
Dwarf (WAD) goats during three consecu-
tive cycles of 14 days each (after peak of 
lactation) increased milk yield by 48 – 78% 
over the control. Highest predicted re-
sponse of DMY occurred during the 3rd 
cycle of bST treatment, thereby changing 
the shape of the lactation curve positively, 
improving persistency of lactation and in-
creasing total milk yield per lactation cycle. 
Doses of bST that elicited optimal milk 
yield response to bST treatment varied in-
consistently with periods of bST treatment 
(stages of lactation). Therefore, in order to 
reduce the complexity of differential injec-
tions administered with respect to stages of 
lactation, the uniform optimal dose of 50.71 
mg per 2 weeks well-estimated by quadratic 
equation for the entire stages of lactation 
studied could be adopted. 
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